Clinical Trial Update: Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating short-term use of dapagliflozin to protect kidney function in chronic renal insufficiency patients undergoing cardiac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Insufficiency

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Dong-A University | Conditions: Renal Insufficiency, Chronic, Cardiac Catheterization | Phase 4 | Status: UNKNOWN